Ipca Laboratories Fundamental Relationships

IPCALAB -- India Stock  

INR 786.95  5.35  0.68%

The Drivers Module shows relationships between Ipca Laboratories's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Ipca Laboratories Limited over time as well as its relative position and ranking within its peers. Please also check Risk vs Return Analysis.

Ipca Laboratories Cash Flow from Operations vs. Number of Employees Fundamental Analysis

Ipca Laboratories Limited is rated below average in number of employees category among related companies. It is rated below average in cash flow from operations category among related companies making about  675,114  of Cash Flow from Operations per Number of Employees.
Ipca Laboratories Limited is rated below average in number of employees category among related companies. The total workforce of Drug Manufacturers - Specialty & Generic industry is currently estimated at about 195,109. Ipca Laboratories holds roughly 5,051 in number of employees claiming about 2.59% of equities under Drug Manufacturers - Specialty & Generic industry.
Number of Employees shows total number of permanent full time and part time employees working for a given company and processed through its payroll.
Ipca Laboratories 
Number of Employees 
 = 
Full Time 
+  
Part Time 
=
5.05K
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investor or analyst to check on the quality of a company earnings.
Ipca Laboratories 
Operating Cash Flow 
 = 
EBITDA 
-  
Taxes 
=
3.41B
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about company having enough liquid resources to meet current and long term debt obligations.

Ipca Laboratories Cash Flow from Operations Comparison

Ipca Laboratories is currently under evaluation in cash flow from operations category among related companies.
Search macroaxis.com